← Leaderboards
Monica Venere
University Of California, San Francisco
$1,726,450
Attributed
$3,156,393
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,156,393 · 5
By mechanism
R01$2,070,282 · 1
R21$789,604 · 2
R03$156,000 · 1
F32$140,507 · 1
Top collaborators
- Stephen C Mack3 shared
- Jeffrey John Chalmers2 shared
- Matthew K Summers1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Erik M Ullian$5,974,065
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorCellsInsightSelf-RenewalPathway InteractionsIn VivoNerve Stem CellGlioblastomaStandard Of CareSolid NeoplasmReportingStem CellsRecurrenceBrainGeneticBaseBrain NeoplasmsNeoplastic CellEffective TherapyAdultGene ExpressionGenesMediating
Grant awards (11)
Role of FACT in ZFTA-RelA fusion driven ependymoma$691,965
R01 · FY2025 · CA · contact PI
Role of FACT in ZFTA-RelA fusion driven ependymoma$657,440
R01 · FY2024 · CA · contact PI
Investigating KIF20A as a therapeutic target in glioblastoma$404,974
R21 · FY2024 · CA
Role of FACT in ZFTA-RelA fusion driven ependymoma$720,877
R01 · FY2023 · CA · contact PI
Development of single cell magnetophoresis to analyze and isolate glioma cancer stem cells$210,426
R21 · FY2021 · CA
Development of single cell magnetophoresis to analyze and isolate glioma cancer stem cells$174,204
R21 · FY2020 · CA
Targeting epigenetic remodeling factors to radiosensitize glioblastoma$78,000
R03 · FY2020 · CA · contact PI
Targeting epigenetic remodeling factors to radiosensitize glioblastoma$78,000
R03 · FY2019 · CA · contact PI
p53, Rb and Ras Pathways in Neural Stem Cell Homeostasis and Transformation$39,583
F32 · FY2009 · NS · contact PI
p53, Rb and Ras Pathways in Neural Stem Cell Homeostasis and Transformation$51,278
F32 · FY2008 · NS · contact PI
p53, Rb and Ras Pathways in Neural Stem Cell Homeostasis and Transformation$49,646
F32 · FY2007 · NS · contact PI